No Data
Express News | Jincheng Pharmaceutical: Subsidiary Receives Drug Registration Certificate for Ademetionine Disulfate Injection
The innovative pharmaceuticals sector witnessed significant developments and policy catalysts this week, with total outbound licensing deals by Chinese innovative drug companies projected to reach USD 200 billion for the year.
① In the first half of 2026, outbound licensing deals for Chinese innovative drugs reached USD 99.7 billion, amounting to approximately 73% of the full-year 2025 total of USD 135.7 billion; ② Recently, the pharmaceutical and biotechnology sector has shown an increasing premium relative to the CSI 300 Index.
Express News | Innovative pharmaceuticals stocks surged amid volatility, with Taiji Group hitting the daily trading limit.
Jincheng Pharmaceutical: 2026 Semi-Annual Performance Forecast of Shandong Jincheng Pharmaceutical Group Co., Ltd.
Express News | AI healthcare concept sees localized volatility; Dian Diagnostics hits the 20% daily limit up.
Optical Fiber Bull Stock Clarification: The Company Has No Business Relationship with NVIDIA! | After-Hours Announcement Highlights
Optical fiber stock urgently clarifies no connection with NVIDIA! Stock with five limit-up days in seven trading sessions issues risk warning; pharmaceutical giant announces its holding subsidiary has signed an exclusive option agreement.